Improved Survival Time: What Can Survival Cure Models Tell Us About Population-based Survival Improvements in Late-stage Colorectal, Ovarian, and Testicular Cancer?

The article discusses the findings of a clinical study that was conducted to examine the effect of treatment advances on the survival of patients with late-stage ovarian, colorectal and testicular cancers. It states that survival cure models were utilized to estimate the gain in life expectancy (GLE) accredited to a rise in the number of cured patients and to the survival of uncured patients. The study found that treatment improvement for ovarian cancer resulted in a total GLE of 2 years while the cure rate in colorectal cancer rose from 29% to 47%.